Squamous cell carcinoma arises from highly proliferative basal layer epithelial cells which normally divide for a short time before detaching from the basement membrane and undergoing terminal differentiation. Basal layer cells in stratified epithelia express the reverse transcriptase known as telomerase. Most human cells do not express telomerase and therefore are subject to loss of telomeric DNA with age due to the inability of lagging strand synthesis to completely replicate chromosomal ends. Late generation telomerase deficient mice exhibit signs of premature aging including reduced function of proliferating cellular compartments. We examined development of squamous cell carcinoma in a telomerase deficient murine background with long and short telomeres.
INTRODUCTION
Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most frequent cancer worldwide (1). HNSCC is a major cause of morbidity and mortality in developing nations, comprising up to 50% of all malignancies. HNSCC is the most common malignant tumor of the oral cavity with 35 ,000 new cases and 8,000 deaths reported in the United States each year (2) . Tobacco carcinogens are the primary etiologic agents of the disease, with age and genetic background as contributory factors. The overall 5 year survival rate of ~50% has not changed significantly in recent decades.
HNSCC arises from stratified squamous epithelium which is composed of multiple cell layers at distinct stages of differentiation with markedly different capacities for proliferation (3, 4) . The highly proliferative basal layer epithelial cells divide for a short time before detaching from the basement membrane, ceasing cell division, and undergoing terminal differentiation which is associated with specific molecular, cellular, and histologic changes. Basal layer cells in stratified epithelia such as epidermis and mucosa express the reverse transcriptase known as telomerase (5, 6) . Telomerase is a ribonucleoprotein which uses an RNA template to synthesize new DNA at chromosomal ends (telomeres). Most human cells do not express telomerase and therefore are subject to loss of telomeric DNA with age due to the inability of lagging strand synthesis to completely replicate chromosomal ends. Loss of telomeric DNA can result in unprotected critically short telomeres, DNA damage response in the form of non-homologous end joining, cell cycle arrest, and apoptosis (7, 8) .
Late generation telomerase deficient mice exhibit signs of premature aging including reduced function of proliferating cellular compartments. Short telomeres in telomerase deficient mice can result in nonreciprocal translocations leading to genomic instability and increased cancer risk when tumor suppressor function is compromised (9) (10) (11) . Telomerase is sufficient to immortalize human fibroblasts, and the vast majority of human cancers overexpress this enzyme which has been associated with poor clinical prognosis (12) (13) (14) .
Telomere length has been shown to predict age related pathologies in humans including cancer (for review see 15) . In human oral epithelium, telomere length has been shown to decrease with age (16, 17) . In a series of cancer patients, 59% of individuals with HNSCC were in the shortest quartile for telomere length measured in peripheral blood lymphocytes (18) . Telomere length also was significantly shorter in tumor cells compared to adjacent normal tissue (19) . Telomerase expression was higher in HNSCC than in oral intraepithelial neoplasia and normal mucosa (20) . High telomerase expression correlated with large tumor size, advanced clinical stage, higher recurrence rate, and lower survival rate in this study.
Our previous studies demonstrated that loss of telomerase expression during suprabasal differentiation of stratified epithelial cells was mediated by formation of a transcriptional repressor complex containing Rb and histone deacetylases at novel E2F sites in the telomerase promoter (21) (22) (23) . Genetic mutations commonly found in epithelial cancers also play a role in maintaining telomerase expression in the suprabasal cells of stratified epithelium (24, 25) . Thus the initial alteration in telomerase expression in dysplastic lesions of stratified epithelia is the failure to appropriately downregulate activity of the gene during suprabasal differentiation (26) . These results raise interesting questions about the development of SCC in a telomerase deficient background and the effects of telomere length on the pathogenesis of this disease. In this study, we used our previously published chemical carcinogenesis protocol (27) which induces primary and metastatic HNSCC in 100% of animals to treat G1 Terc-/-mice with long telomeres and G5 Terc-/-animals with short telomeres. Our results indicate that decreased metastasis is the primary feature of HNSCC in G1 Terc-/-mice which correlates with increased apoptotic cells in these tumors. Critically short telomeres can compensate for loss of telomerase activity in metastasis of HNSCC arising in G5 Terc-/-mice due to increased genomic instability. HNSCC in Terc-/-mice showed genetic similarities with the human disease. Microarray analysis revealed that primary and metastatic HNSCC express markedly different gene expression profiles. We concluded that telomere shortening promotes metastasis during carcinogenesis. was purchased from The Jackson Laboratory (Bar Harbor, ME). C57Bl6J mice were used as Terc+/+ control animals. Mice were housed in approved environmentally controlled facilities on 12 h light-dark cycles with unlimited access to food and water. Genotyping was performed according to The Jackson Laboratory protocol using extracted tail DNA as the PCR template. Terc-/-mice were bred for five generations to create G5 animals. Twenty male and female 1 month old Terc+/+, G1 Terc-/-, G5 Terc-/-were dosed orally twice weekly using 25 μg dimethylbenzanthracene (DMBA) dissolved in 20 μl ethanol. The time course and number of tumors were recorded for each animal. Mice were euthanized when any institutional criterion for experimental neoplasia in rodents was met. Euthanized mice were photographed and complete necropsies were performed. A portion of each tumor specimen was flash frozen in liquid nitrogen or fixed in 4% buffered formaldehyde for 16 h at room temperature.
Histopathology and Immunohistochemistry. Tumor tissue was dehydrated in an ethanol
series, cleared in xylene, and embedded in paraffin. Five micrometer sections were prepared and mounted on poly-L-lysine coated slides. Representative sections were stained with hematoxylin and eosin and histologically evaluated by a pathologist. Immunohistochemical analysis was performed using a commercially available kit (Invitrogen, Carlsbad, CA). Sections were incubated at 60 0 C for 30 minutes and deparaffinized in xylene. Endogenous peroxidase activity was quenched by incubation in a 9:1 methanol/30% hydrogen peroxide solution for 10 minutes at room temperature.
Sections were rehydrated in PBS (pH 7.4) for 10 minutes at room temperature. Sections were blocked with 10% normal serum for 10 minutes at room temperature followed by incubation with anti-7 EGFR, cyclin A, cyclin B, cyclin D, cyclin E, c-myc, and PCNA antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for 16 hours at room temperature. After three washes in PBS, the sections were incubated with secondary antibody conjugated to biotin for 10 minutes at room temperature. After additional washes in PBS, the sections were incubated with streptavidin conjugated horseradish peroxidase for 10 minutes at room temperature. Following final washes in PBS, antigen-antibody complexes were detected by incubation with hydrogen peroxide substrate solution containing aminoethylcarbazole chromogen reagent. Slides were rinsed in distilled water, coverslipped using aqueous mounting medium, and allowed to dry at room temperature. The relative intensities of the completed immunohistochemical reactions were evaluated using light microscopy by independent trained observers who were unaware of the mouse genotypes. A scale of 0 to 3 was used to score relative intensity, with 0 corresponding to no detectable immunoreactivity and 1, 2, and 3 equivalent to low, moderate, and high expression respectively. Nonparametric data was analyzed by Fisher exact test.
Western Blot. Protein was extracted from microdissected primary and metastatic SCC in 1x
Laemmli buffer. 50 μg total cellular protein was separated by SDS-PAGE on 10% resolving gels under denaturing and reducing conditions. Separated proteins were electroblotted to PVDF membranes according to manufacturer's recommendations (Roche Applied Science). Blots were incubated with antibodies to EGFR, cyclin A, cyclin B, cyclin D, cyclin E, c-myc, PCNA, p53, or β-actin Serial dilutions of mouse genomic DNA were amplified for standard curve calculation. Relative input amount of telomere PCR was divided by relative input amount of 36B4 PCR of the same sample.
Real time PCR was performed a minimum of 3 times for each sample and the ratio of telomere:36B4
was calculated. The average of these ratios is the average telomere length ratio. probe was hybridized to the metaphase spreads according to manufacturer's recommendations (Dako, Carpinteria, CA). After washing, slides were coverslipped using Vectashield with DAPI (Vector Laboratories) and photographed using fluorescence microscopy. 
RNA Extraction and Gene Expression

RESULTS
We characterized the phenotype of chemically induced HNSCC in wild type, G1 Terc-/-, and G5 Terc-/-mice. We first examined the gross and histopathologic appearance of wild type, G1 Terc-/-, and G5 Terc-/-tumors. As shown in Fig. 1A , primary HNSCC in wild type and Terc-/-mice which began the induction protocol at 1 month old grew to 1.5 cm within 12 weeks after initial appearance.
Histopathologic analysis of primary HNSCC in wild type and Terc-/-mice demonstrated well differentiated SCC in 70% (46 of 66 tumors analyzed) and moderate differentiation in 30% of cases (Fig. 1B, C) . Histopathologic analysis of metastatic HNSCC in these groups of mice revealed moderately differentiated SCC in 90% of cases (178 of 202 tumors analyzed) and 10% well differentiated tumors (Fig. 1D) . We concluded that the gross and histopathologic appearance of tumors was similar in wild type and Terc-/-mice.
We detected cervical lymph node metastasis in all groups of mice (Table 1) . G1 Terc-/-mice showed statistically fewer metastatic nodes than wild type animals. 49 of 120 nodes were positive in G1 Terc-/-mice compared to 82 of 120 nodes analyzed in Terc+/+ animals (p<0.01). However, no statistically significant differences in the number of metastatic lymph nodes were observed between wild type and G5 Terc-/-mice (71 positive nodes of 120 analyzed; p<0.09). These results indicate that loss of telomerase activity in primary HNSCC reduces numbers of metastatic cells. However, short telomeres promoted metastasis in HNSCC arising in G5 Terc-/-mice. We examined number, latency, and growth rates of tumors in Terc+/+, G1 Terc-/-, and G5 Terc-/-mice. Tumor latency was 22 weeks in Terc+/+ mice and slightly increased (23 weeks; p<0.4) in Terc-/-mice (Fig. 2) . Tumors Terc-/-; data not shown). We concluded that there were no significant differences between Terc groups in number of tumors, latency, or growth rate. We hypothesized that increased metastasis in G5 Terc-/-mice may be due to critically short telomeres giving rise to genomic instability and metastatic clones. To test this hypothesis, we compared average telomere length ratios in Terc+/+, G1 Terc-/-, and G5 Terc-/-normal mucosa and primary SCC (n=20 for each group). Compared to Terc+/+ tumors, average telomere length ratios were significantly lower in G1 Terc-/-and G5 Terc-/-cancers (0.78, 0.6, and 0.27 respectively; p<0.02). Average telomere length ratios were significantly lower in tumors compared to normal mucosa (2.1 vs. 0.78 for Terc+/+, 2.0 vs. 0.6 for G1 Terc-/-, and 1.22 vs. 0.27; p<0.001). We reasoned that this significant telomere shortening in G5 Terc-/-tumors might result in signal free ends, chromosomal fusions, and aneuploidy leading to increased numbers of metastatic clones. We Robertsonian type fusions were rare in tumor cells from Terc+/+ mice. Tumor cells from G1 Terc-/-tumors higher frequency of signal free ends (6%) compared to Terc+/+ cells (Fig. 5B) . The overall number of chromosomes was higher in G1 Terc-/-tumor cells compared to Terc+/+ cancers (modal chromosomal number 50; p<0.02). In contrast, cells from G5 Terc-/-tumors showed significantly increased signal free ends (15%; p<0.05), chromosomal fusions (7%; p<0.003), and a high degree of aneuploidy consistent with telomere dysfunction during tumorigenesis (Fig. 5C ). G5 Terc-/-tumors exhibited the highest degree of aneuploidy (modal chromosome number 71; p<0.001). We concluded that increased genomic instability correlated with telomere dysfunction in G5 Terc-/-squamous cell carcinomas.
Given that short telomeres in G5 Terc-/-mice resulted in increased genomic instability leading to increased metastasis, we hypothesized that specific changes in gene copy number would be associated with this phenotype. We tested this hypothesis using comparative genomic hybridization as described in Materials and Methods. The statistically significant DNA copy number changes (p < 0.01) are shown in Table 2 . Terc+/+ tumors showed gain of copy numbers in mouse chromosomal regions 1A, 9B, and 11A. Loss of copy number was observed on mouse chromosomal region 17D.
In G1 Terc-/-tumors, gain of copy number was observed in mouse chromosomal regions 1A1, 11A, 11B, and 16B. In G5 Terc-/-tumors, gain of copy number was observed on mouse chromosomal 
/-HNSCC correlates with specific DNA copy number changes in these tumors compared to Terc+/+ or G1 Terc-/-mice.
We hypothesized that the increased genomic instability observed in G5 Terc-/-tumors would result in increased gene expression changes resulting in metastasis. To test this hypothesis, we performed global gene expression profiling on G1 Terc-/-and G5 Terc-/-microdissected tumor cells using microarray analysis. We previously published global gene expression changes between primary and metastatic HNSCC in Terc+/+ mice (27) . The most statistically significant gene expression changes are shown in Tables 3-5. As shown in Table 3 We also examined differences between primary and metastatic SCC in G5 Terc-/-mice. As shown in Table 5 expression correlated with expression of the proliferation marker PCNA in a significant number of cancers (109 cases, p<0.02). The percentage of Terc-/-tumors overexpressing each of these cell cycle regulatory proteins was similar to that found in our previous studies on human and Terc+/+ mouse tumor tissue (26, 27) . We also compared expression of these gene products in G1 Terc-/-primary and metastatic SCC by western blot. As shown in Fig. 6C , EGFR expression by western blot ranged from undetectable to more than 50 fold induction in primary SCC (p < 0.0001). Cyclin A expression was more than 40 fold induced between low and high level expressing tumors (p < 0.002).
Cyclin E expression was more than 18 fold induced between low and high expressing SCC (p < 0.005). c-myc expression was 4 fold induced between low and high expressing tumors (p < 0.01).
PCNA expression was 20 fold induced between low and high expressing SCC (p < 0.03). p53 levels varied by 12 fold between low and high expressing tumors (p < 0.01). In metastatic SCC, PCNA expression varied by 8 fold among low and high expressing tumors ( Fig. 6D ; p < 0.04). Cyclin B levels were 25 fold induced between low and high expressing metastatic SCC (p < 0.01). Cyclin D levels were more than 100 fold induced between low and high expressing tumors (p < 0.0005). p53 expression was not detected in metastatic SCC in G1 or G5 Terc-/-mice (Fig. 6D, E ), in agreement with our previously published study (27) . We concluded that the mouse Terc-/-HNSCC model recapitulated expression of specific cell cycle regulatory proteins observed in Terc+/+ tumors. 
DISCUSSION
The basal layer of stratified epithelia expresses low levels of telomerase activity, and squamous cell carcinomas are believed to arise as the result of malignant transformation of these rapidly dividing cells (5, 6) . During the process of stratified epithelial transformation, premalignant lesions express progressively higher levels of telomerase (29) . In order to determine the effects of telomerase deficiency on development of HNSCC, we used our previously developed chemical carcinogenesis protocol in G1 (long telomeres) and G5 (short telomeres) Terc-/-mice. Previous studies using the DMBA/TPA mouse skin carcinogenesis protocol demonstrated that telomerase deficient mice were resistant to tumor formation (30) . These results correlate with reduced metastasis in our DMBA induced Terc-/-HNSCC model. Conversely overexpression of telomerase in mouse skin resulted in tumor promotion using the DMBA/TPA protocol (31) . An important difference in our study is the use of multiple DMBA doses which produces metastatic SCC in all mice compared to the DMBA/TPA protocol in which a low rate of malignant conversion is observed. Our results using oral mucosa as the target tissue showed no significant differences in primary tumor latency (other than slight increases in Terc-/-mice) or growth rates in wild type, G1 Terc-/-, or G5 Terc-/-mice.
These results indicate that primary tumor formation in our model is independent of telomerase activity and telomere length. This may be due to the fact that low levels of telomerase activity in normal stratified epithelia of wild type mice during early tumorigenesis are insufficient to prevent the telomere erosion resulting from increased cell divisions. These shorter telomeres may result in the minimal differences in primary tumor latency and proliferation when compared to those in telomerase deficient animals. A key finding of our study was decreased cervical lymph node metastasis in HNSCC arising in G1 Terc-/-mice. In agreement with these findings, metastasis has been associated with increased telomerase activity has been noted in tumors from different tissues, including human oral cancer (32) (33) (34) . Telomere uncapping results in cellular senescence and programmed cell death, which may limit production of metastatic clones as shown in G1 Terc-/-tumors in our present study. High levels of telomerase activity may allow chromosomal end maintenance in these potential clones until sufficient genetic changes have occurred to produce metastasis. In this regard, long telomeres have been associated with decreased survival in human HNSCC (19) .
In contrast to the decreased metastasis observed in G1 Terc-/-HNSCC, tumors from G5 Terc-/-mice regain metastatic capability. G5 Terc-/-HNSCC demonstrated an increased percentage of telomeric signal free ends in metaphase chromosomal spreads compared to G1 Terc-/-or Terc+/+ cancers. This percentage was higher than observed in spontaneous tumors arising in Terc/p53 null mice, likely due to additional telomere shortening resulting from the chemical carcinogenesis protocol (9) . We hypothesized that increased genomic instability during tumorigenesis as the result of critically short telomeres in G5 Terc-/-mice might more efficiently produce metastatic clones. To test this hypothesis, we performed DNA copy number analysis using comparative genomic hybridization on tumor cells from Terc+/+, G1 Terc-/-, and G5 Terc-/-mice. The increased DNA copy number changes observed in G5 Terc-/-metastatic tumors were statistically significant. These changes were associated with markedly increased chromosomal fusions and aneuploidy. A number of these DNA copy number changes correspond to those found in human HNSCC (35; 17D and 3p, 19C1-2 and 9p21, 16B and 3q). Higher resolution analysis of these copy number changes will reveal specific genes which are amplified or deleted in metastatic HNSCC. shown to increase tumor cell proliferation, invasion and metastasis were overexpressed in Terc-/-metastatic tumors (38) . Receptor signaling pathways were also deregulated in Terc-/-mice. G protein coupled receptors are overexpressed in human cancers such as lung (39) . The G protein coupled receptor GPR18 was dramatically overexpressed in Terc-/-metastatic HNSCC in our mouse model. Ephrin signaling was downregulated in metastatic Terc-/-HNSCC tumors, which has also been demonstrated in colorectal cancer (40) . Notch signaling has been shown to suppress invasive tumor growth (41) . In this regard, Notch 3 and Notch ligands Jagged 1 and 2 were downregulated in Terc-/-tumors and the Notch antagonist Numb was upregulated. JAK/STAT signaling was upregulated in our mouse HNSCC model, and also is enhanced in the human disease (42).
Phosphatidylinositol-3-kinase subunits were upregulated in HNSCC in our mouse models, which are important survival factors for these tumors (43) . In addition to striking downregulation of genes controlling differentiation and intercellular adhesion, the gene expression profile of HNSCC metastases in this model was notable for the large number of differentially regulated genes involved in cytoskeletal organization, cell migration, and invasion. Previous reports have shown that Rho family members are overexpressed in human cancer (44) , and expression of Rac2 was increased in our mouse HNSCC model. The nonreceptor tyrosine kinase c-src (upregulated in Terc-/-metastatic HNSCC) is overexpressed in human HNSCC and regulates both proliferation and invasion by these cells (45) . Members of the nuclear hormone receptor family such as peroxisome proliferator activated 
receptor γ were upregulated in Terc-/-metastatic HNSCC. PPARγ has been shown to regulate differentiation of epidermis (46) ; the complex PPARγ gene expression changes in our mouse models will be the subject of future investigation.
In summary, critically short telomeres promote metastasis in Terc-/-HNSCC. Future experiments will determine the types of DNA damage in tumor initiating cancer stem cells that occur at early stages of tumor development in Terc-/-mice that account for the distinct phenotypic differences in HNSCC in these models. Average telomere length analysis of Terc+/+, G1 Terc-/-, and G5 Terc-/-normal mucosa and squamous cell carcinomas was performed as described in Materials and Methods. These experiments were performed three times with similar results. 
